Insights

Gathering insights about Aeglea BioTherapeutics…

Similar companies to Aeglea BioTherapeutics

Aeglea BioTherapeutics Tech Stack

Aeglea BioTherapeutics uses 8 technology products and services including Cloudflare, MySQL, Google Font API, and more. Explore Aeglea BioTherapeutics's tech stack below.

Cloudflare
Content Management System
MySQL
Database
Google Font API
Font Scripts
Font Awesome
Font Scripts
jQuery Migrate
Javascript Libraries
Microsoft
Miscellaneous
HTTP/3
Miscellaneous
PHP
Programming Languages

Media & News

Aeglea BioTherapeutics's Email Address Formats

Aeglea BioTherapeutics uses at least 2 format(s):

Aeglea BioTherapeutics Email Formats	Example	Percentage
FLast@aegleabio.com	JDoe@aegleabio.com	78%
First.Last@aegleabio.com	John.Doe@aegleabio.com	21%
FirstLast@aegleabio.com	JohnDoe@aegleabio.com	1%
FLast@aeglea.com	JDoe@aeglea.com	100%

Frequently Asked Questions

Where is Aeglea BioTherapeutics's headquarters located?

Aeglea BioTherapeutics's main headquarters is located at 805 Las Cimas Pkwy Suite 100 Austin, Texas 78746 US. The company has employees across 2 continents, including North AmericaEurope.

What is Aeglea BioTherapeutics's phone number?

You can contact Aeglea BioTherapeutics's main corporate office by phone at

+1-512-942-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aeglea BioTherapeutics's stock symbol?

Aeglea BioTherapeutics is a publicly traded company; the company's stock symbol is SYRE.

What is Aeglea BioTherapeutics's official website and social media links?

Aeglea BioTherapeutics's official website is aeglea.com and has social profiles on LinkedIn.

How much revenue does Aeglea BioTherapeutics generate?

As of August 2024, Aeglea BioTherapeutics's annual revenue reached $15M.

What is Aeglea BioTherapeutics's SIC code NAICS code?

Aeglea BioTherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aeglea BioTherapeutics have currently?

As of August 2024, Aeglea BioTherapeutics has approximately 51 employees across 2 continents, including North AmericaEurope. Key team members include Chief Legal Officer And Corporate Secretary: H. A. K.Chief Development Officer: E. B.Chief Operating Officer: C. T.. Explore Aeglea BioTherapeutics's employee directory with LeadIQ.

What industry does Aeglea BioTherapeutics belong to?

Aeglea BioTherapeutics operates in the Biotechnology Research industry.

What technology does Aeglea BioTherapeutics use?

Aeglea BioTherapeutics's tech stack includes CloudflareMySQLGoogle Font APIFont AwesomejQuery MigrateMicrosoftHTTP/3PHP.

What is Aeglea BioTherapeutics's email format?

Aeglea BioTherapeutics's email format typically follows the pattern of . Find more Aeglea BioTherapeutics email formats with LeadIQ.

How much funding has Aeglea BioTherapeutics raised to date?

As of August 2024, Aeglea BioTherapeutics has raised $210M in funding. The last funding round occurred on Jun 22, 2023 for $210M.

When was Aeglea BioTherapeutics founded?

Aeglea BioTherapeutics was founded in 2013.

Aeglea BioTherapeutics

Biotechnology ResearchTexas, United States51-200 Employees

With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD.

For more information, please visit http://aeglea.com.

Company Overview

Headquarters: 805 Las Cimas Pkwy Suite 100 Austin, Texas 78746 US
Phone number: ✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-512-942-****
Website: aeglea.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: SYRE
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2013
Employees: 51-200

Media & News

Funding & Financials

$210M
Aeglea BioTherapeutics has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 22, 2023 in the amount of $210M.
$10M$50M
Aeglea BioTherapeutics's revenue is in the range of $10M$50M

Funding & Financials

$210M
Aeglea BioTherapeutics has raised a total of $210M of funding over 3 rounds. Their latest funding round was raised on Jun 22, 2023 in the amount of $210M.
$10M$50M
Aeglea BioTherapeutics's revenue is in the range of $10M$50M

Company Leadership

H. A. K.
Chief Legal Officer And Corporate Secretary
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. B.
Chief Development Officer
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. T.
Chief Operating Officer
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. A.
Chief Legal Officer And Corporate Secretary
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. M.
Vice President Of Quality
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. S.
Vice President, Clinical Operations And Data Management
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. M.
Vice President Of Quality
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. S.
Vp, Commercial Operations And Alliance Management
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. R.
Vp Research And Development
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. D.
Head Of Translational Medicine And Clinical Pharmacology
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Aeglea BioTherapeutics and Millions of Other Companies
Sign up for full access to Aeglea BioTherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Aeglea BioTherapeutics

Abeona Therapeutics

Madrigal Pharmaceuticals

CymaBay Therapeutics

Intercept Pharmaceuticals

Terns Pharmaceuticals

Aeglea BioTherapeutics Tech Stack

Media & News

Aeglea BioTherapeutics, Inc. is developing treatments for inflammatory bowel disease.

Aeglea BioTherapeutics, Inc. is developing next-generation therapeutic combinations for the treatment of IBD.

Aeglea BioTherapeutics, Inc. hired Heidy Abreu King-Jones as chief legal officer on Sep 19th '23.

Aeglea BioTherapeutics, Inc. hired Scott Burrows as Chief Financial Officer on Sep 5th '23.

Aeglea BioTherapeutics, Inc. is developing treatments for rare metabolic diseases.

Aeglea BioTherapeutics, Inc. acquired Spyre Infostructure Inc. on Jun 1st '23.

Aeglea BioTherapeutics, Inc. acquired Morningstar on Jun 22nd '23.

Aeglea BioTherapeutics's Email Address Formats

Frequently Asked Questions

Where is Aeglea BioTherapeutics's headquarters located?

What is Aeglea BioTherapeutics's phone number?

What is Aeglea BioTherapeutics's stock symbol?

What is Aeglea BioTherapeutics's official website and social media links?

How much revenue does Aeglea BioTherapeutics generate?

What is Aeglea BioTherapeutics's SIC code NAICS code?

How many employees does Aeglea BioTherapeutics have currently?

What industry does Aeglea BioTherapeutics belong to?

What technology does Aeglea BioTherapeutics use?

What is Aeglea BioTherapeutics's email format?

How much funding has Aeglea BioTherapeutics raised to date?

When was Aeglea BioTherapeutics founded?

Aeglea BioTherapeutics

Company Overview

Media & News

Aeglea BioTherapeutics, Inc. is developing treatments for inflammatory bowel disease.

Aeglea BioTherapeutics, Inc. is developing next-generation therapeutic combinations for the treatment of IBD.

Aeglea BioTherapeutics, Inc. hired Heidy Abreu King-Jones as chief legal officer on Sep 19th '23.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?